The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction
- 1 September 1988
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (7), 347-351
- https://doi.org/10.1016/0002-9149(88)90956-3
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- INTRAVENOUS STREPTOKINASE GIVEN WITHIN 0-4 HOURS OF ONSET OF MYOCARDIAL INFARCTION REDUCED MORTALITY IN ISIS-2The Lancet, 1987
- Intravenous Anisoylated Plasminogen Streptokinase Activator Complex versus Intravenous Streptokinase in Evolving Myocardial InfarctionDrugs, 1987
- Preclinical Pharmacological Evaluation of Anisoylated Plasminogen Streptokinase Activator ComplexDrugs, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Intravenous short-term infusion of streptokinase in acute myocardial infarction.Circulation, 1983